Novartis to file meningitis vaccine for infants
Links shared publicly online about this topic.
- 776total visits
Novartis to file meningitis vaccine for infants
View full resource at health.yahoo.net
Tags: Vaccination, Meningitis, Children's Health, Vaccine, Novartis
Most Recently Shared on November 7, 2011 at 9:40 am By:
Novartis drug helps in severe childhood arthritis http://t.co/Yx1tVen5
FDA evaluates Novartis' meningitis vaccine Menveo for babies - Related Stories - AAP SmartBrief
smartbrief.com — “The FDA is considering whether to approve Novartis' meningococcal vaccine Menveo for infants as young as 2 months. Menveo is already used in people ages 2 to 55. ” View full resource at smartbrief.com
Most Recently Shared on June 19, 2011 at 8:34 pm By:
Clara Song Pediatrician, Physician, and Doctor
FDA evaluates Novartis' meningitis vaccine Menveo for babies http://t.co/EAbEcM7
Novartis Bexsero pivotal study data on meningococcal serogroup B presented at ESPID
news-medical.net — “New data from a pivotal study in more than 1,800 infants show that Novartis candidate vaccine Bexsero induces a robust immune response to meningococcal serogroup B when given alone or when co-administered with other routine vaccines.” View full resource at news-medical.net
Most Recently Shared on June 15, 2011 at 1:12 pm By:
Meningitis News: Novartis Bexsero pivotal study data on meningococcal serogroup B presented at ESPID: New data f... http://bit.ly/mnQtmV
New data show potential for Novartis Meningitis B vaccine (4CMenB) candidate to cover majority of diverse meningococcal serogroup B strains - Drugs.com MedNews
drugs.com — “Data show that antibodies induced by Novartis 4CMenB candidate killed 85 percent of a large collection of MenB strains in adults and 74 percent in infants 1 , w” View full resource at drugs.com
Most Recently Shared on November 5, 2010 at 2:14 pm By:
Drugs and Devices OW OW Health
New data show potential for Novartis Meningitis B vaccine (4CMenB) candidate to cover majority of diverse ... http://bit.ly/d3x6Uo #drug
UPDATE 1-Novartis to file meningitis vaccine for infants | Reuters
reuters.com — “* Study shows Menveo immunises infants from 2 months of age * Highest rate of infections occurs in first year of life (adds details, background) ZURICH, Oct 25 (Reuters) - Swiss drugmaker Novartis” View full resource at reuters.com
Most Recently Shared on October 25, 2010 at 11:51 am By:
John Carroll Health Communicator
Big Phase III for meningitis vax comes in positive, Novartis says it is ready to file for approval in US/Europe. http://reut.rs/cO4KWp
Novartis to file meningitis vaccine for infants | Reuters
reuters.com — “ZURICH (Reuters) - Swiss drugmaker Novartis AG wants to file its meningitis vaccine Menveo for use in small infants in the United States and Europe after a late-stage study with children of this age group” View full resource at reuters.com
Most Recently Shared on October 25, 2010 at 10:00 am By:
Hisham Rana, MD Doctor and Physician
News: Novartis to file meningitis vaccine for infants http://reut.rs/9HooDG - #health #pharma
Novartis to file meningitis vaccine for infants
health.yahoo.net — “Swiss drugmaker Novartis AG wants to file its meningitis vaccine Menveo for use in small infants in the United States and Europe after a late-stage study with children of this age group was successful.” View full resource at health.yahoo.net
Most Recently Shared on October 25, 2010 at 7:08 am By:
Jennifer Ann Grisso Active Health Library and Nurse
Novartis to file meningitis vaccine for infants: Swiss drugmaker Novartis AG wants to file its meningitis vaccine ... http://bit.ly/9H9slY
Novartis to file meningitis vaccine for infants | Reuters
reuters.com — “ZURICH (Reuters) - Swiss drugmaker Novartis AG wants to file its meningitis vaccine Menveo for use in small infants in the United States and Europe after a late-stage study with children of this age group” View full resource at reuters.com
Most Recently Shared on October 25, 2010 at 6:51 am By:
Novartis to file meningitis vaccine for infants http://dlvr.it/7VHx8
Novartis' meningitis B vax passes test - FierceVaccines
fiercevaccines.com — “Novartis released promising data from its Phase III trial for 4CMenB, a meningitis B vaccine developed via Novartis' "reverse vaccinology." The study, which involved 3,600 infants from five Read more...” View full resource at fiercevaccines.com
Most Recently Shared on September 16, 2010 at 12:03 pm By:
Novartis' meningitis B vaccine passes test. http://bit.ly/abesJz
Advertisement
